Börje Haraldsson

Börje Haraldsson has a diverse and extensive work experience.

Börje currently holds multiple roles at Oncorena AB, including Chief Executive Officer and Chief Scientific Officer. As one of the cofounders, they have played a crucial role in securing Series A investment and initiating the first site at Karolinska. The focus of Oncorena is to provide potentially curative therapy for patients with advanced renal cancer.

In addition to their roles at Oncorena AB, Haraldsson is also a Professor at Sahlgrenska Academy at the University of Gothenburg. Börje has held various positions at the university, including Professor of Physiology (unpaid), Professor and Chair of Nephrology, Director of the University Board, Vice Dean, Researcher in Integrative Physiology, Associate Professor, University Assistant, and Ph.D. Student.

Haraldsson has also served as a Board Member at UGLK Science AB and as Chief Executive Officer at Creorena AB.

Prior to their current roles, Haraldsson worked at Novartis as a Global Program Head and was the Chair of the Nephrology Strategic Working Group at Novartis Institutes for BioMedical Research (NIBR). In these positions, they played a significant role in defining the renal strategy of the company and leading projects in Translational Medicine - Autoimmunity, Transplantation, and Immunology.

Börje has also worked as a Senior Consultant and Attending Physician at Sahlgrenska University Hospital and as a Visiting Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Haraldsson spent a sabbatical at Mount Sinai Medical Center, collaborating with renowned professors on an interesting project.

Haraldsson began their career with an internship at the hospital in Mölndal, under Västra Götalandsregionen.

Overall, Börje Haraldsson's work experience spans various leadership, scientific, and medical roles, showcasing their expertise in nephrology and their contributions to the field of healthcare.

Börje Haraldsson began their education at the University of Gothenburg in 1976, where they pursued a degree in Medicine. Börje successfully completed their MD program in 1982. Subsequently, they continued their studies at the same university and earned a PhD in Physiology from 1982 to 1986. In 1986, they also obtained the certification of "Leg. Läkare," becoming a fully licensed physician.

In terms of additional certifications, Börje Haraldsson received multiple significant recognitions throughout their career. In 1988, they qualified as a professor of Medical Physics after an independent review by the University of Gothenburg. Börje later achieved the position of associate professor of Physiology at the same university in March 1989. In July 1995, they became a board-certified Nephrologist in Sweden, recognized by Socialstyrelsen.

Moving forward, Börje Haraldsson received the qualification of professor of Physiology at the University of Gothenburg in June 1995. Börje then achieved the prestigious Professorship of Nephrology in competition and after external review at the same university in January 2001. Furthermore, they gained fellowship status in the American Society of Nephrology in September 2000 and became a Fellow of the American Society of Transplantation in March 2021.

The provided information does not indicate any additional degrees Börje Haraldsson obtained after completing their MD, PhD, and Leg. Läkare programs at the University of Gothenburg.